Table 3 The descriptive analysis as per the diagnosis of patients on clozapine
Characteristic | TRS | TRSAD | TRBD | TD | Schizophrenia with suicidality | Neuroacanthocytosis | Parkinsons with PF | PD |
|---|---|---|---|---|---|---|---|---|
Age | ||||||||
 20–29 | 10 | 0 | 1 | 0 | 5 | 0 | 0 | 0 |
 30–39 | 33 | 5 | 1 | 1 | 0 | 1 | 0 | 1 |
 40–49 | 16 | 0 | 2 | 1 | 0 | 0 | 0 | 0 |
 More than 49 | 7 | 0 | 1 | 1 | 1 | 0 | 1 | 0 |
Gender | ||||||||
 Male | 48 | 4 | 5 | 3 | 6 | 1 | 1 | 1 |
 Female | 18 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
Dose of clozapine (mgs) | ||||||||
 Median (range) | 325 (150–800) | 300 (200–600) | 500 (400–500) | 100 (50–200) | 500 (200–800) | 100 | 75 | 400 |
Antipsychotics used prior to clozapine | ||||||||
 Haloperidol | 52 | 3 | 3 | 3 | 4 | 0 | 0 | 1 |
 Chlorpromazine | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
 Olanzapine | 51 | 5 | 2 | 2 | 3 | 1 | 1 | 0 |
 Resperidone | 24 | 2 | 2 | 1 | 5 | 0 | 0 | 0 |
 Quetiapine | 0 | 2 | 2 | 0 | 0 | 0 | 1 | 0 |
 Amisulpride | 10 | 0 | 0 | 1 | 0 | 0 | 0 | 0 |
 Aripiprazole | 3 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
 Paliperidone | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |